CDKN2A and Barrett esophagus: For instance, in a longitudinal case series of 19 BE patients with HGD/IMC undergoing RFA, Zeki et al. reported that five patients with persistent HGD/IMC had the same TP53 or CDKN2A mutations in specimens taken before and after RFA/EMR [21].